Why the study?
Does inhibition of JAK/STAT signaling with tyrphostin AG490 or losartan reduce ischemia/reperfusion injury in adult rat myocardium?
Population
Adult rat myocardium subjected to ischemia/reperfusion
Comparison
Losartan or tyrphostin AG490 vs Untreated hearts subjected to ischemia/reperfusion
Design
Preclinical
Authors
Loading...
Provides preclinical support for JAK/STAT inhibition in rat I/R injury; leaves open translation to human cardioprotection.
Does inhibition of JAK/STAT signaling with tyrphostin AG490 or losartan reduce ischemia/reperfusion injury in adult rat myocardium?
Inhibition of the JAK/STAT signaling pathway reduces myocardial infarct size and apoptosis while improving functional hemodynamics in a rat model of ischemia/reperfusion injury.
Mascareno et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: